N0018926RB011 - Drug Demand Reduction Program, Fentanyl/Norfentanyl Immunoassay Reagent Kits

Combined Synopsis/SolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in NORFOLK, VA
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
N0018926RB011
Opportunity Type
Combined Synopsis/Solicitation
Sub-Agency
DEPT OF THE NAVY
Office
NAVSUP FLT LOG CTR NORFOLK
Posted Date
Wednesday, May 27, 2026
Response Deadline
Friday, June 26, 2026
PSC Code
6550
Set-Aside
No Set Aside
Place of Performance
NORFOLK, VA, 23511-3392
Status
Active

Description

The Department of War (DoW) Drug Demand Reduction Program (DDRP) has a requirement for Food & Drug Administration (FDA) and Quality Management Documented Fentanyl/Norfentanyl Immunoassay Reagent Kits for use with the currently installed Beckman Coulter AU5800 series systems. The reagents shall be capable of detecting fentanyl/norfentanyl in human urine samples. The reagent kits are required for an ordering period of five (5) years. The estimated number of tests shall accommodate up to 500,000 tests per month. Please see attached Statement of Work and copy of Solicitation N0018926RB011.

Why This Opportunity Matters

The Department of DEFENSE is actively seeking qualified contractors for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in NORFOLK, VA. This set-aside designation means eligible businesses face reduced competition from larger firms.